Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Efficacy and Safety of CT-P10, Rituximab Biosimilar Candidate, Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks
- Authors
- 유대현
- Issue Date
- 14-Nov-2016
- Place
- Washington DC, USA
- Conference Name
- ACR 2016
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.